Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement peptides and mast cell triggering

A Erdei1, I Pecht

  • 1Department of Immunology, Eotvos Lorand University, God, Hungary. erdann@alfa.elte.hu

Immunology Letters
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.

Journal of endocrinological investigation·2014
Same author

Evaluation of the metabolic changes during hemodialysis by signal averaged ECG.

Die Pharmazie·2012
Same author

Immunology Letters. Introduction.

Immunology letters·2012
Same author

Addition of chlorine during water purification reduces iodine content of drinking water and contributes to iodine deficiency.

Journal of endocrinological investigation·2011
Same author

Evaluation of the thyroid function of healthy pregnant women by five different hormone assays.

Die Pharmazie·2010
Same author

Nicotinic acid tolerance test.

British medical journal·2010
Same journal

Th1 recruitment in atopic dermatitis is due to suppression rather than amplification of Th2.

Immunology letters·2026
Same journal

Interleukin-6: A Potential Link in the Pathophysiology of Restless Legs Syndrome.

Immunology letters·2026
Same journal

The dendritic cell identity crisis: Why do conflicting classifications demand a consensus framework?

Immunology letters·2026
Same journal

The malignancy within: what cancer teaches us about human bonds.

Immunology letters·2026
Same journal

Progranulin enhances complement component 5a-primed neutrophil activation in antineutrophil cytoplasmic antibody-associated vasculitis.

Immunology letters·2026
Same journal

The newly identified role of TRIM72, an E3 ligase, in NINJ1-mediated plasma membrane rupture: focus on its anti-inflammatory function.

Immunology letters·2026
See all related articles

Complement peptide C3a inhibits IgE-mediated triggering of mucosal mast cells, a novel finding. This inhibitory effect, observed at nanomolar concentrations, contrasts with C5a

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Mucosal mast cells are typically unresponsive to peptidergic stimuli.
  • Mast cell activation involves Fc epsilon receptors (Fc epsilonRI) and complement peptides like C3a and C5a.

Purpose of the Study:

  • To investigate the relationship between Fc epsilonRI-mediated stimulation and complement peptide stimulation in rat mucosal-type mast cells (RBL-2H3).
  • To identify novel functions of C3a and C5a in mast cell responses.

Main Methods:

  • Utilized the rat mucosal-type mast cell line RBL-2H3.
  • Assessed mast cell secretory response to stimulation via Fc epsilonRI and complement peptides C3a and C5a.
  • Quantified the concentrations of C3a required for inhibition of antigen-induced degranulation.

Main Results:

Related Experiment Videos

  • Demonstrated a novel inhibitory function of C3a on IgE-mediated triggering of mucosal mast cells.
  • C3a's inhibitory activity is likely mediated through interaction with the beta-chain of Fc epsilonRI.
  • Nanomolar concentrations of C3a were sufficient for inhibition, unlike micromolar concentrations needed for connective tissue mast cell activation.
  • The anaphylatoxic peptide C5a showed no activity in this specific test system.

Conclusions:

  • C3a possesses a previously unrecognized inhibitory role in mucosal mast cell activation.
  • The mechanism involves C3a's interaction with Fc epsilonRI.
  • Mucosal mast cells exhibit distinct responses to complement peptides compared to connective tissue mast cells, with C3a acting as a potent inhibitor at low concentrations.